STOK logo
Stoke Therapeutics, Inc.(STOK)
Last print unknown agoAbout this dataData status
$24.82▲0.65 (2.69%)Stale · unknown oldEarnings · Nov 3

STOK Cash Conversion Ratio

0.87×TTM

Retrieved:

STOK FY Cash Conversion Ratio
STOK FY Cash Conversion Ratio1.88×-7.42×
2022-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

STOK cash conversion ratio history

Free cash flow divided by net income. The available annual fiscal periods series contains 4 observations from Dec 31, 2022 to Dec 31, 2025.

Stoke Therapeutics Inc Cash Conversion Ratio — Annual fiscal periods
Period endingCash Conversion Ratio
-6.5236×
0.9783×
0.7897×
0.3545×

Compare cash conversion ratio

All STOK financial metrics · STOK stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.